Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors
Vaxart appoints Dr. James Breitmeyer, a seasoned biopharmaceutical executive with extensive clinical development and regulatory experience, to its Board of Directors. This strategic move is aimed at strengthening the company's expertise as it progresses in developing innovative oral vaccines based on its proprietary delivery platform, targeting dis…